Skip to main content
Clinical Trials/NCT03105115
NCT03105115CompletedNot Applicable

Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine

Seoul National University Hospital1 site in 1 country56 target enrollmentStarted: May 25, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
56
Locations
1
Primary Endpoint
Two segment sensory block regression time

Study Overview

Brief Summary

Intravenous infusion of dexmedetomidine during procedure was known to be associated prolonged duration of spinal anesthesia. In patients receiving dexmedetomidine infusion during procedure, it has been not evaluated whether use of adjuvant intrathecal fentanyl had additional prolonging effect on duration of spinal anesthesia or not. Therefore, the investigators planned this trial to compare clinical outcomes in patients receiving spinal anesthesia with heavy bupivacaine only and heavy bupivacaine plus fentanyl adjuvant.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients undergoing total knee replacement arthroplasty under spinal anesthesia

Exclusion Criteria

  • Contraindication of spinal anesthesia
  • inability to communicate
  • morbid obesity (BMI > 30kg/m2)
  • spine abnormality
  • severe cardiac dysfunction
  • Height <155cm, or > 180cm
  • contraindication to fentanyl

Arms & Interventions

intrathecal fentanyl

Active Comparator

heavy bupivacaine 14mg and fentanyl 20mcg will be injected intrathecally during spinal anesthesia

Intervention: fentanyl (Drug)

bupivacaine only

Experimental

heavy bupivacaine 14mg will be injected intrathecally during spinal anesthesia

Intervention: bupivacaine only (Drug)

Outcomes

Primary Outcomes

Two segment sensory block regression time

Time Frame: From completion of spinal anesthesia, to end of surgery, an expected average of 2 hours

Time from highest sensory block level to two segment regression

Secondary Outcomes

  • postoperative pain score(at op day, at postoperative 1st day, at postoperative 2nd day)
  • motor block(From completion of spinal anesthesia, to end of surgery, an expected average of 2 hours)
  • intraoperative incidence of hypotension(From completion of spinal anesthesia, to end of surgery, an expected average of 2 hours)
  • postoperative nausea and vomiting(at op day, at postoperative 1st day, at postoperative 2nd day)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jin-Tae Kim

Associate professor

Seoul National University Hospital

Study Sites (1)

Loading locations...

Similar Trials

Effect of Intrathecal Fentanyl on Spinal... | Clinical Trial